Clinical Trial Update: A Study of Combination Treatment With MabThera (Rituximab) and RoActemra (Tocilizumab) Versus RoActemra in Patients With Rheumatoid Arthritis With an Incomplete Response to Methotrexate [Phase 2]

View source ↗

Summary

Phase 2 randomized study evaluating combination therapy with Rituximab (MabThera) and Tocilizumab (RoActemra) versus Tocilizumab alone in rheumatoid arthritis p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• MabThera (rituximab)
• RoActemra (tocilizumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Rheumatoid Arthritis | Phase 2 | Status: TERMINATED | Results posted: 2014-12-24